Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-03-30Pilot Translational Study of Sonazoid-Enhanced Ultrasonography for Sentinel Lymph Node Mapping in Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2020-03-20Vaccination of Melanoma Patients (Stage II-IV) With ImmuFact IMP321, Tumor Antigenic Peptides and Montanide
-
CLINICAL_TRIALS study record update · 2020-03-12Phase 2 Trial of Karenitecin (BNP1350) in Patients With Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2020-03-11A Pilot Trial of Ipilimumab With Nivolumab for Participants With Resected Stages IIIB/IIIC/ IV Melanoma
-
CLINICAL_TRIALS study record update · 2020-03-03Adjuvant Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Sarcomas, Melanomas, Germ Cell Tumors, or Epithelial Malignancies Metastatic to Lungs, Pleura, or Mediastinum
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-03-02An Expanded Access Program for AM0010 (Pegilodecakin) Subcutaneous Injection
-
CLINICAL_TRIALS study record update · 2020-03-02Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus GM-CSF-in-adjuvant, Followed by Systemic Low-dose-IL-2 Administration, in Patients With High Risk Melanoma.
-
CLINICAL_TRIALS study record update · 2020-02-25Phase 1 Suicide Plus Immune Gene Therapy for Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-24Evaluating Attenuation Correction Methods Applied to PET/MRI
-
CLINICAL_TRIALS study record update · 2020-02-20An Exploratory Prospective, Open-label, Unicentric Study With Cross-over Design, Comparing Lymphoseek® vs. Albumin Nanocolloid for Image- Guided Sentinel Lymph Node Mapping in Head and Neck, Melanoma and Breast Cancer.
-
CLINICAL_TRIALS study record update · 2020-02-20A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody
-
CLINICAL_TRIALS study record update · 2020-02-19A Phase II Trial of High Dose Interleukin-2 (HDIL-2) With Recombinant MAGE-A3 Protein Combined With Adjuvant System AS15 (recMAGE-A3 + AS15) in Patients With Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-17Incidence, Clinical Management and Molecular Factors Associated With the Development of Immune-related Adverse Events in Cancer Patients Receiving PD-1 and PD-L1 Inhibitors: a Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2020-02-17A Randomized Phase II Study of Vemurafenib Plus Cobimetinib Continuous Versus Intermittent, in Previously Untreated BRAFV600- Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-13HYPAZ: An Open-label Investigation Into Hypertension Induced by Pazopanib Therapy
-
CLINICAL_TRIALS study record update · 2020-02-12Phase II Clinical Trial of the MEK Inhibitor Trametinib With the AKT Inhibitor GSK2141795 in BRAF Wild-type Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-11A Phase IB Trial of PVSRIPO in Combination With Nivolumab in Patients With Recurrent PD-1 Refractory Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-11A Phase 1b Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors (ILLUMINATE-101)
-
CLINICAL_TRIALS study record update · 2020-02-10Neoadjuvant GM-CSF Treatment and Modulation of Immune Cell Profile of the SLN in Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-07A Phase 1b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma
-
CLINICAL_TRIALS study record update · 2020-02-05Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2020-02-05Effect of Skin Self-examination Education Delivered During the Mammography Experience.
-
CLINICAL_TRIALS study record update · 2020-01-31A Randomized, run-in, Multi-center, Phase II Study of Nivolumab Combined With Ipilimumab and Guadecitabine or Nivolumab Combined With Ipilimumab in Melanoma and NSCLC Patients Resistant to Anti-PD-1/PD-L1 (NIBIT-ML1)
-
CLINICAL_TRIALS study record update · 2020-01-22A Phase I Open-Label Dose Escalation of GD3 ADC (Pfizer PF-06688992) in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma (B802WI209568)
-
CLINICAL_TRIALS study record update · 2020-01-22A Phase I/II Study of an Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancers